These may include body weight, HbA1c (a 2- to 3-month blood sugar marker), fasting glucose, adverse events, treatment discontinuation, and patient characteristics
In a follow-up analysis of data obtained from Q-SYMBIO clinical trials (Mortensen et al., 2014), Alehagen and colleagues were able to show that in elderly healthy participants who received selenium and CoQ 10 supplementation for over 4 years, an increase in insulin-like growth factor 1 (IGF-1) and postprandial insulin-like growth factor-binding protein 1 (IGFBP-1) levels, and greater age-corrected IGF-1 score based on the standard deviation of the mean value were observed compared with placebo-treated individuals (Alehagen et al., 2017)
No product-specific analytical report is currently linked on this page
Wang H, Liu C, Zhao Y, Zhang W, Xu K, Li D, et al
Key Takeaway: The safety of taking moringa while on a GLP-1 medication depends largely on your current metabolic health, your dosage, and whether you have underlying conditions like type 2 diabetes
